Critics on Policy of Soy-Based Infant Formula in Indonesia: Compared to Australian and New Zealand Food Standards

Agnescia Clarissa Sera

Abstract

Background: World Health Organiza on (WHO) recommends breast milk as sole and the most complete infant food during the first 6 months. However, in certain circumstances, when breas eeding is not possible, not de- sired or not advised, infant formulas like those are made of soy can be given to newborns. However, the safety of long-term use soy-based formula has been argued due to the possible adverse effects of phytoestrogen, phytates and aluminum in human body as well as the consequences of agrochemicals residue. Therefore, those problems should be taken into account while developing, reviewing or amending policy of infant formulas. This ar cle re- views the adequacy of soy-based infant formula policy in Indonesia to an cipate issues in SIF consump on. Methods: Australian and New Zealand Food Standards Code was used to compared to the decree of Indonesian NADFC. The results were described narra vely and analyzed from the perspec ve of the author.
Results: Accordingly, only small aspects of SIF are regulated in Indonesian policy. The use of SPI for SIF in In- donesia is not a compulsory though scien fically another source may trigger diarrhea in newborn baby. No clause related to aluminum content, zinc to copper ra o, isoflavone level, GM soy and pes cide residue found in In- donesian policy.
Conclusion: Apparently, very limited provision regarding SIF has been covered by Indonesian policy. The regu- la on of SIF marketed and manufactured in Indonesia should be more specific and developed based on recent clinical and epidemiological studies. On the other hand, Indonesia needs a comprehensive system where society may par cipate in reviewing the laws.

Full Text:

PDF

References

Abo-Elsoud, M., Hashem, N., El-Din, A. N., Kamel, K., and Hassan, G. (2019). Soybean iso avone a ects in rab- bits: E ects on metabolism, antioxidant capacity, hormonal balance and reproductive performance. Animal reproduction science, 203:52–60, DOI: 10.1016/j.anireprosci.2019.02.007.

Blomkamp, E., Sholikin, M. N., Nursyamsi, F., Lewis, J. M., and Toumbourou, T. (2017). Understanding poli- cymaking in indonesia: In search of a policy cycle. no. June.

Bosch, A. M. (2011). Classic galactosemia: dietary dilemmas. J Inherit Metab Dis, 34(2):257–260, DOI: 10.1007/s10545-010-9157-8.

Burrell, S.-A. M. and Exley, C. (2010). There is (still) too much aluminium in infant formulas. BMC pediatrics, 10(1):63, DOI: 10.1186/1471-2431-10-63.

Chen, A. and Rogan, W. J. (2004). Iso avones in soy infant formula: a review of evidence for endocrine and other activity in infants. Annu. Rev. Nutr., 24(1):33–54, DOI: 10.1146/annurev.nutr.24.101603.064950.

Chuchu, N., Patel, B., Sebastian, B., and Exley, C. (2013). The aluminium content of infant formulas remains too high. BMC pediatrics, 13(1):162, DOI: 10.1186/1471-2431-13-162.

Esch, H. L., Kleider, C., Sche er, A., and Lehmann, L. (2016). Iso avones: toxicological aspects and e icacy. In Nutraceuticals, pages 465–487. Elsevier, DOI: 10.1016/B978-0-12-802147-7.00034-6.

FSANZ (2019a). Australia new zealand food standards code – standard 2.9.1 – infant formula products. https: //www.legislation.gov.au/Details/F2017C00332.

FSANZ (2019b). The safe food system. retrieved from food standards australia and new zealand. http://www.foodstandards.gov.au/about/safefoodsystem/pages/default.aspx.

Gomez, B. G., Perez-Corona, M. T., and Madrid, Y. (2016). Availability of zinc from infant formula by in vitro methods (solubility and dialyzability) and size-exclusion chromatography coupled to inductively coupled plasma-mass spectrometry. Journal of dairy science, 99(12):9405–9414, DOI: 10.3168/jds.2016-11405.

Lucht, J. M. (2015). Public acceptance of plant biotechnology and gm crops. Viruses, 7(8):4254–4281, DOI: 10.3390/v7082819.

McCarver, G., Bhatia, J., Chambers, C., Clarke, R., Etzel, R., Foster, W., Hoyer, P., Leeder, J. S., Peters, J. M., Rissman, E., et al. (2011). Ntp-cerhr expert panel report on the developmental toxicity of soy infant formula. Birth Defects Research Part B: Developmental and Reproductive Toxicology, 92(5):421–468, DOI: 10.1002/bdrb.20314.

Redgrove, J., Rodriguez, I., Mahadevan-Bava, S., and Exley, C. (2019). Prescription infant formulas are con- taminated with aluminium. International journal of environmental research and public health, 16(5):899, DOI: 10.3390/ijerph16050899.

Stallings, V. A., Adgent, M. A., Umbach, D. A., Zemel, B. S., Kelly, A., Schall, J. I., Ford, E. G., James, K., Darge, K., Botelho, J. C., et al. (2017). Soy-based infant formula feeding and impact on estrogen-responsive tissue. The FASEB Journal, 31(1_supplement):958–2, DOI: 10.1096/fasebj.31.1_supplement.958.2.

Upson, K., Harmon, Q. E., Laughlin-Tommaso, S. K., Umbach, D. M., and Baird, D. D. (2016). Soy-based in- fant formula feeding and heavy menstrual bleeding among young african american women. Epidemiology (Cambridge, Mass.), 27(5):716, DOI: 10.1097/EDE.0000000000000508.

Vandenplas, Y., Castrellon, P. G., Rivas, R., Gutiérrez, C. J., Garcia, L. D., Jimenez, J. E., Anzo, A., Hegar, B., and Alarcon, P. (2014). Safety of soya-based infant formulas in children. British Journal of Nutrition, 111(8):1340– 1360, DOI: 10.1017/S0007114513003942.

Westmark, C. J. (2017). Soy-based therapeutic baby formulas: testable hypotheses regarding the pros and cons. Frontiers in nutrition, 3:59, DOI: 10.3389/fnut.2016.00059.

Yu, J., Bi, X., Yu, B., and Chen, D. (2016). Iso avones: anti-in ammatory bene t and possible caveats. Nutrients, 8(6):361, DOI: 10.3390/nu8060361.

Zhu, Y., Xu, H., Li, M., Gao, Z., Huang, J., Liu, L., Huang, X., and Li, Y. (2016). Daidzein impairs leydig cell testosterone production and sertoli cell function in neonatal mouse testes: An in vitro study. Molecular medicine reports, 14(6):5325–5333, DOI: 10.3892/mmr.2016.5896.

Refbacks

  • There are currently no refbacks.